PARDES BIOSCIENCES, INC.
BalancedPRDS·US·🇺🇸 US
55%buys·45%sales
183 transactions$23.2MTotal buys·11 buys
$0Total sells·9 sells
2424 insiders
Last: Aug 31, 2023
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Aug 31, 23 | AUERBACH MARK | Disposition | - | |
| Aug 31, 23 | AUERBACH MARK | Disposition | - | |
| Aug 31, 23 | AUERBACH MARK | Disposition | - | |
| Aug 31, 23 | Autor Deborah M. | Disposition | - | |
| Aug 31, 23 | Autor Deborah M. | Disposition | - | |
| Aug 31, 23 | Autor Deborah M. | Disposition | - | |
| Aug 31, 23 | Autor Deborah M. | Disposition | - | |
| Aug 31, 23 | Hamill Laura | Disposition | - | |
| Aug 31, 23 | Hamill Laura | Disposition | - | |
| Aug 31, 23 | Hamill Laura | Disposition | - |
PARDES BIOSCIENCES, INC. (PRDS) has recorded 183 insider transactions from 24 insiders. Total insider buying volume stands at $23.2M, while total selling volume is $0. Insider activity shows a balanced mix of buying and selling.
PARDES BIOSCIENCES, INC. (PRDS) has recorded 183 insider operations, including 11 open-market purchases ($23.2M), 9 sales ($0) and 163 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is balanced.
PARDES BIOSCIENCES, INC. shows moderate insider activity with 5 active months out of the last 12, typical of a company whose trading windows are concentrated around financial disclosures.
Among the most active insiders are Tananbaum James B. (CEO), WIGGANS THOMAS G (CEO) & Lopatin Uri A (CEO), with respectively 283, 272, 15 transactions.
Across all 183 recorded transactions, the breakdown by type is: grant (60, 33%), disposition (58, 32%), exercise (36, 20%), buys (11, 6%), other (9, 5%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
PARDES BIOSCIENCES, INC. has recorded 183 insider operations in total, including 11 open-market purchases ($23.2M), 9 sales ($0) and 163 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on August 31, 2023.
Insiders at PARDES BIOSCIENCES, INC. show balanced activity with 55% purchases and 45% sales. Total buy volume is $23.2M versus $0 in sales.
InsiderLens tracks 24 insiders at PARDES BIOSCIENCES, INC. (PRDS). Tananbaum James B. (CEO, 283 tx), WIGGANS THOMAS G (CEO, 272 tx), Lopatin Uri A (CEO, 15 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for PRDS is neutral, based on a 55% buy ratio across 20 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for PARDES BIOSCIENCES, INC. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.